Spray Dried Biologics For Injectable Dosage Forms

In this discussion, industry specialists share how spray drying is increasingly being used to address formulation and delivery challenges for modern biologics. Based on extensive hands‑on experience, they describe how the technique can gently convert sensitive proteins, peptides, and antibodies from liquid into stable dry powders without compromising activity. The conversation walks through the basics of spray drying, from early development systems through to clinical and GMP‑scale manufacturing, highlighting its scalability, continuous operation, and ability to fine‑tune particle size and structure. A key theme is the rising interest in ultra‑high‑concentration injectable biologics, including subcutaneous and depot formats, where issues such as stability, viscosity, and ease of injection become critical. Hear the contrast between spray drying and freeze drying, pointing to benefits around speed, flexibility, and particle control. The discussion concludes with a look at aseptic spray drying and its potential role in future sterile biologic products aimed at improving dosing and patient convenience.